Abstract
Neonatal mortality remains a major public health challenge, as reductions have stagnated worldwide despite cost-effective interventions in recent years. The temporal evolution of its determinants is insufficiently studied. This study aimed to analyze the dynamics of factors associated with neonatal death in Madagascar between 2003 and 2021.
A secondary analysis was conducted using data from the 2003, 2008, and 2021 Demographic and Health Surveys (DHS) of Madagascar. The study population is focused on children under the age of 5 years at the time of these surveys. The death of a newborn within 30 days after birth constitutes the outcome variable. A multilevel binomial logistic regression was performed.
The number of children under 5 included in the analysis were 5,415 in 2003, 12,448 in 2008 and 12,399 in 2021. The prevalence of neonatal deaths was 3.05% in 2003, 2.42% in 2008, and 2.56% in 2021. Persistent significant associations with neonatal death were observed for low birth weight, lack of breastfeeding, medium-sized households, large households, and high birth weight. A loss of statistical significance of the association with neonatal death over time was observed for a birth interval of 2 to 3 years and 4 years and more, mother’s age 40-49 years, and use of mosquito net by the mother. In 2021, new significant associations with neonatal mortality were identified in the province of Toliara, absence of difficulty in accessing health centers, 4 to 7 ANC visits, and supervised delivery.
The factors associated with neonatal mortality, which have worsened over time in Madagascar, include birth weight abnormalities, delivery in the presence of qualified personnel, and evaluation of neonatal health before discharge from the facility. This deterioration underscores the urgency of improving the quality of perinatal care in healthcare facilities, beyond mere geographical accessibility.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was obtained for this study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted based on publicly accessible secondary data, with individual observations anonymized. Thus, this secondary analysis is considered exempt research according to the guidelines of the Johns Hopkins Institutional Review Board. The DHS databases are created from standard DHS questionnaires, which have been reviewed and approved by the institutional ethics review board (IRB) of ICF for compliance with the U.S. Department of Health and Human Services regulations for the protection of human subjects (45 CFR 46). At the national level, the text of voluntary consent was prepared by ICF Macro based on the standard text developed by ICF Macro. They were reviewed and approved by the Committee for Biomedical Research Ethics (CERBM) at the Ministry of Public Health in Madagascar. Further documentation on ethical issues relating to the surveys is available at https://dhsprogram.com/methodology/Protecting-the-Privacy-of-DHS-Survey-Respondents.cfm.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used in this study is openly available to the public, following the submission of the study protocol to the official DHS program website https://dhsprogram.com/data/available-datasets.cfm.
